Omer specializes in representing companies and individuals in diverse and complex litigation cases involving all aspects of commercial law.
In this framework, Omer accompanies a long list of clients, including domestic and international corporations, public companies, private companies, and businessmen, in class actions, derivative claims, shareholder and control disputes, capital markets and securities lawsuits, real estate disputes, administrative appeals, Supreme Court appeals, and more.
Before joining Barnea, Omer worked at a boutique Israeli litigation firm. Prior to his legal studies, Omer worked for seven years as a researcher and editor at Israel’s Channel 2.
Interdisciplinary Center Herzliya, LL.B., 2013
Member of the Israel Bar Association since 2014
News and updates - Omer Keydar:
District Court Ruling: Azrieli Foundation Exempt from Paying Taxes on Dividends
An Israeli district court rejected the Israel Tax Authority’s attempt to force the Azrieli Foundation to pay taxes in the amount of tens of millions of shekels for dividends it received and continues to receive due to its holding in Azrieli Group's shares. The court accepted the tax appeal, which was filed by Barnea Jaffa Lande, and ruled that the Azrieli Foundation, a non-profit organization that works for the public good in Israel, is not the controlling owner of Azrieli Group and is therefore entitled to a tax exemption. The court ruled, among other things, that the ITA’s position could have a chilling effect in relation to business entities’ support of philanthropic associations. Our firm's Zohar Lande, Eyal Nachshon, and Omer Keydar represented the Azrieli Foundation throughout the proceedings, which lasted about five years. This ruling, a long-awaited achievement, will strengthen and encourage the continued philanthropic activity led by the foundation.
Barnea Representing Knight Therapeutics in Minority Discrimination Lawsuit in Israel
Our firm is representing Knight Therapeutics, a Canadian public company that holds 28% of Israeli pharmaceutical company Medison's shares, in a lawsuit alleging the deprivation of its rights as a minority shareholder in Medison. The company is represented by Advs. Zohar Lande, Eyal Nachshon, Omer Keydar and Eitan Sivan of our Litigation Department.
Continued Representation of Eyal Shamir in Claim for Brokerage Fees
Advs. Zohar Lande, Eyal Nachshon, and Omer Keydar of the firm's Litigation Department continue to represent the businessman Eyal Shamir in a lawsuit against British Israel. Shamir claims he was not paid a brokerage fee for the merger between British Israel and Melisron.